Mark Kilby

Accepting PhD Students

PhD projects

Mark Kilby is a clinical scientist working in the field of fetal medicine and therapy.

Professor Kilby has special clinical expertise and a clinical research interest in:
1.Prenatal diagnosis (the detection of fetal anomalies).
2.Intrauterine fetal growth restriction.
3.Fetal therapy (the treatment of the baby in-utero).
4.The management of Monochorionic twins and high order pregnancies.
5.He participates (with his colleague, Dr Denise Williams), a bi-monthly joint Fetal Medicine/Clinical Genetics Clinic. He has provided evidence based research to inform the introduction of prenatal genomics into clinical practice.

His work though focuses upon diverse themes crossing the interface between laboratory-based research and translational clinical trials in valuating diagnostic tests and therapeutic interventions.

The laboratory-based work focuses upon aspects of fetal and fetoplacental endocrine/paracrine signalling including the roles of thyroid hormone, glucocorticoids and vitamin D. His group also investigates the cellular immunity (especially T-cell) between the fetoplacental unit and the mother and the control of immunomodulation in human pregnancy. His translational work has focused upon diagnostic accuracy of testing in pregnancy and the evaluation of fetal therapy in singleton and complex multiple pregnancy.

Professor Kilby supervises both clinical and non-clinical doctoral researcher projects.